Cargando…
Oral succimer decreases the gastrointestinal absorption of lead in juvenile monkeys.
Although succimer (Chemet, meso-2,3-dimercaptosuccinic acid, DMSA) is considered to be a safe and effective chelating agent for the treatment of lead poisoning in humans, there is concern that it may increase the gastrointestinal (GI) absorption and retention of Pb from exposures suffered concurrent...
Autores principales: | Cremin, J D, Luck, M L, Laughlin, N K, Smith, D R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1240344/ https://www.ncbi.nlm.nih.gov/pubmed/11445516 |
Ejemplares similares
-
Succimer Gets TLC
Publicado: (1993) -
Effect of succimer on growth of preschool children with moderate blood lead levels.
por: Peterson, Karen E, et al.
Publicado: (2004) -
Reductions in blood lead overestimate reductions in brain lead following repeated succimer regimens in a rodent model of childhood lead exposure.
por: Stangle, Diane E, et al.
Publicado: (2004) -
Succimer Chelation Improves Learning, Attention, and Arousal Regulation in Lead-Exposed Rats but Produces Lasting Cognitive Impairment in the Absence of Lead Exposure
por: Stangle, Diane E., et al.
Publicado: (2007) -
Another Look at Succimer: Cognitive Deficits May Be Reversible After All
por: Washam, Cynthia
Publicado: (2007)